Anke Reinacher‐Schick

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Dominik Paul Modest, Ingrid Ricard, Volker Heinemann et al. · Annals of Oncology · 2016 · 344 citations · Full text

Medicine, Biostatistics, Oncology +17

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

Alexander Baraniskin, Jan Kuhnhenn, Uwe Schlegel et al. · Blood · 2011 · 304 citations

Medicine, Neurology, Oncology +13

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller et al. · The Lancet Oncology · 2015 · 251 citations

Medicine, Oncology, Pharmacology +12

Feasibility and Diagnostic Utility of Video Capsule Endoscopy for the Detection of Small Bowel Polyps in Patients with Hereditary Polyposis Syndromes

Karsten Schulmann, Stephan Hollerbach, Katja Kraus et al. · The American Journal of Gastroenterology · 2005 · 248 citations

Medicine, Clinical Sciences, Oncology +17